SECUKINUMAB REDUCES SACROILIAC JOINT AND SPINAL INFLAMMATION IN PATIENTS WITH ANKYLOSING SPONDYLITIS: MRI DATA FROM A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY (MEASURE 1)

ANNALS OF THE RHEUMATIC DISEASES

BMJ PUBLISHING GROUP

1. Novartis